Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population.
作者信息
Haley C S, Waring R H, Mitchell S C, Shah R R, Idle J R, Smith R L
出版信息
Xenobiotica. 1985 May;15(5):445-50. doi: 10.3109/00498258509045015.
PMID:4036168
Abstract
One-hundred-and-twenty volunteers and three families were investigated for possible association between the sulphoxidation of S-carboxymethyl-L-cysteine and the debrisoquine hydroxylation polymorphism. The observed individual variations in these two metabolic reactions were shown not to be concordant (rs = 0.068) and any heritable factors controlling the major aspects of these phenomena do not co-segregate.
摘要
相似文献
1
Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population.
Xenobiotica. 1985 May;15(5):445-50. doi: 10.3109/00498258509045015.
2
Debrisoquine hydroxylation in a Polish population.
Eur J Clin Pharmacol. 1995;47(6):503-5. doi: 10.1007/BF00193702.
3
Lack of defect in oxidative hydroxylation of debrisoquine in a patient with halothane hepatitis.氟烷性肝炎患者中去甲丙咪嗪氧化羟基化无缺陷。
Eur J Clin Pharmacol. 1990;38(6):633-4. doi: 10.1007/BF00278596.
4
The influence of cimetidine on debrisoquine 4-hydroxylation in extensive metabolizers.西咪替丁对快代谢者中异喹胍4-羟化作用的影响。
Eur J Clin Pharmacol. 1989;36(3):319-21. doi: 10.1007/BF00558167.
5
Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians.
Pharmacogenetics. 1994 Jun;4(3):159-61. doi: 10.1097/00008571-199406000-00007.
6
Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations.南太平洋波利尼西亚人群中异喹胍（CYP2D6）和氯胍（CYP2C19）的基因多态性。
Eur J Clin Pharmacol. 1998 Jul;54(5):431-5. doi: 10.1007/s002280050488.
7
Quinidine inhibition of debrisoquine S(+)-4- and 7-hydroxylations in Chinese of different CYP2D6 genotypes.奎尼丁对不同CYP2D6基因型中国人中去甲丙咪嗪S(+)-4-和7-羟化作用的抑制
Pharmacogenetics. 1993 Apr;3(2):94-100. doi: 10.1097/00008571-199304000-00005.
8
Stereoselective 4-hydroxylation of debrisoquine in Nigerians.
Biochem Pharmacol. 1988 Jan 1;37(1):97-8. doi: 10.1016/0006-2952(88)90759-9.
9
Debrisoquine and S-mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia.居住在爱沙尼亚的俄罗斯人群中的异喹胍和S-美芬妥因羟基化多态性
Eur J Clin Pharmacol. 1997;53(3-4):257-60. doi: 10.1007/s002280050372.
10
引用本文的文献
1
Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.奎尼丁以及对那些被归类为异喹胍代谢缓慢者体内消除受损药物的鉴定。
Br J Clin Pharmacol. 1986 Dec;22(6):739-43. doi: 10.1111/j.1365-2125.1986.tb02969.x.
Zotero 插件